Literature DB >> 3860396

Possible function of bronchial surfactant.

B Lachmann.   

Abstract

In addition to stabilizing peripheral airways bronchial surfactant is essential for bronchoalveolar transport mechanisms including non-ciliary and ciliary mucus transport. Furthermore, it could play a role in the masking of smooth muscle receptors with respect to contractile stimuli. A model has recently been devised in which predominant impairment of the bronchial surfactant is induced by a combination of positive or negative pressure ventilation with tracheal saline instillation (approximately 3 ml/kg). It is shown that tracheal instillation or inhalation of surfactant could be a promising approach for the treatment of damage to the bronchial surfactant system. In vitro investigations of the transport properties of various phospholipid mixtures and of detergents revealed that the transport function of surface active materials is independent of both the hysteresis characteristics and the surface tension changes during compression and expansion in the Langmuir trough.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860396

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN: 0106-4347


  4 in total

Review 1.  Ventilation and secretion of pulmonary surfactant.

Authors:  H Wirtz; M Schmidt
Journal:  Clin Investig       Date:  1992-01

2.  Prevention by ambroxol of bronchopulmonary complications after upper abdominal surgery: double-blind Italian multicenter clinical study versus placebo.

Authors:  G Fegiz
Journal:  Lung       Date:  1991       Impact factor: 2.584

3.  Lung protein leakage in respiratory failure induced by a hybridoma making monoclonal antibody to the hydrophobic surfactant-associated polypeptide SP-B.

Authors:  Y Suzuki; B Robertson; Y Fujita; G Grossmann; K Kogishi; T Curstedt
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

4.  Acute and chronic effects of xanthine oxidase on lung thorax-compliance in guinea pigs.

Authors:  O D Saugstad; G Becher; M Grossmann; G Merker; A Oddoy; B Lachmann
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.